Radiopharmaceutics & PET Radiochemistry

The training provided by the Radiopharmaceutics & PET Radiochemistry MSc programme will equip you to work as a radiopharmaceutical scientist in a PET radiochemistry centre (cyclotron unit) or a conventional radiopharmacy, to provide diagnostic and therapeutic radiopharmaceuticals to nuclear medicine centres or to study for a PhD.

KEY BENEFITS

• The only MSc level course in PET Radiochemistry subject worldwide.
• Includes a two-week work experience placement in a hospital, PET centre or industrial cyclotron centre.
• Multidisciplinary programme open to graduates in various science disciplines: chemists, bio-scientists, physicists, pharmacists.
• Located in the heart of London.

PURPOSETo educate, train and equip students from a chemistry, pharmacy or related background to enter employment as radiopharmaceutical scientists in a PET radiochemistry centre (cyclotron unit) or in a conventional radiopharmacy, to provide diagnostic and therapeutic radiopharmaceuticals to nuclear medicine centres or specialised commercial centres, or to study for PhD in this field.

DESCRIPTION

The MSc in Radiopharmaceutics & PET Radiochemistry at King's College London is unique, not only in the UK but worldwide. Radiopharmaceutics is a growing international industry facing a major skills shortage - graduates from this programme are in demand - whether in hospitals, preparing radiopharmaceuticals for cancer patients, in research in universities or industry or in the drug industry which is increasingly using PET (Positron Electron Tomography) as a major drug development tool.

The programme provides opportunities for students to develop their knowledge, understanding and skills in the principles and practice of radiopharmaceutical science; manufacturing and quality assurance of radiopharmaceuticals; appreciation of the design and operation of accelerator machines including cyclotrons; synthesis of radiopharmaceuticals from cyclotron-produced radionuclides; application of radiopharmaceuticals in biomedical research and clinical nuclear medicine.